Nova News
FIRST EYE CENTRE IN MALAYSIA TO UTILISE ARTIFICIAL INTELLIGENCE (AI) FOR RETINAL DISEASE DETECTION
Oct 2020 – According to the International Diabetes Federation, there are just below 1.8 million undiagnosed diabetics in Malaysia. It is estimated that 17 out of every 100 in Malaysia is suffering from this chronic yet silent condition. One of the most common complication from diabetes is diabetic retinopathy which is asymptomatic during early stages but can lead to blindness…
EYRIS WELCOMES DR GAVIN TAN TO OUR ADVISORY BOARD
Oct 2020 – We are pleased to welcome Assoc Prof Gavin Tan onto our Advisory Board. Gavin is a Senior Consultant at the Retina Centre in Singapore National Eye Centre, specialising in General Ophthalmology and Cataract Surgery, and a subspecialist in vitreo-retinal surgery. In addition, he is actively involved with academic research and leads multiple Clinical Trials at the Singapore…
NEW ADVENTURE FOR EYRIS IN VIETNAM
14 Oct 2020 – Vietnam Global Innovation (VGI), powered by Quest Ventures, concluded its extensive three-month program last week. Focused on providing Singaporean start-ups an accelerated entry into Vietnam, VGI has pushed through the challenges brought on by COVID-19 to provide its participants with knowledge and insights for their next stage of growth. EyRIS is one of the start-ups that…
EYRIS AWARDED 5-YEAR CONTRACT TO DEPLOY SELENA+
Sep 2020 – EyRIS was awarded a 5-year contract for the deployment of SELENA+, an deep learning system to detect diabetic retinopathy, glaucoma and age-related macular degeneration in the Singapore Integrated Diabetic Retinopathy Program (SiDRP). This award is not only a milestone for EyRIS but also a world first in showcasing real world adoption of an artificial intelligence medical device…
EYRIS CO-FOUNDERS RECOGNISED FOR CONTRIBUTION IN TECH SECTOR
Sep 2020 – We extend our heartiest congratulations to both co-founders of EyRIS, Profs Wynne Hsu and Lee Mong Li for making it onto the inaugural Singapore 100 Women in Tech (SG100WIT) List. The SGWIT100 2020 recognises the contributions of women in the tech sector and nominees are celebrated for their ability to influence, inspire and impact on community and…
Building & Construction Authority (BCA), Singapore Awards Project to NOVA to Localise IFC Data Model
Aug 2020 – Singapore’s Building and Construction Authority (BCA) has awarded to novaCITYNETS, a subsidiary of Nova MSC the project to develop a Localised Industry Foundation Class (IFC) Information Model. BCA and its appointed representatives plans to adopt the internationally-accepted standard Industry Foundation Classes (IFC) as the base for the common representation for BIM model submissions by Qualified Persons (QP)…
NOVA ESTABLISHES DEX-LAB PTE LTD TO FOCUS ON ARTIFICAL INTELLIGENCE AND ROBOTICS
April 2020 – 4 May 2020: As part of the Group’s strategy to continuously improve its product offering, the Group has today incorporated a new company called DEX-lab Pte Ltd (“DEX-lab”) in Singapore to focus on the development and marketing of artificial intelligence (“AI”) related products and services in the robotics industry. The Group will hold a 60% stake in…
EYRIS SIGNS MOU WITH SINGAPORE OPTOMETRIST ASSOCIATION
Mar 2020 – Many amongst the general population are oblivious to the need for regular eye examination. To underscore this need, most of these eye conditions are silent and asymptomatic during early stages which can be vision threatening when it takes a turn for the worse. As professionals regulated by the Optometrist and Optician Board (OOB), optometrists are trained and…
AI to detect papilledema from ocular fundus photographs
April 2020 – Papilledema is optic disc swelling due to high intracranial pressure possibly due to many factors such as cerebral hemorrhage, head trauma, meningitis, hydrocephalus, spinal cord lesions, impairment of cerebral sinus drainage and idiopathic intracranial hypertension (IIH). Irrespective of the cause, visual loss is the feared morbidity of papilledema, and the main mechanism of optic nerve damage is…
EyRIS Founders Review Factors Influencing Performance of DLS
Mar 2020 – While the latest development in AI has been proven to be relatively accurate detecting retinal diseases, there has been little insight on what impacts clinical deployment in real-world settings. In a recent publication in NPJ Digital Medicine, EyRIS founders shared their findings from a systematic review of literature on possible factors, both image-related and technical affecting the…
NOVA SECURES NATIONWIDE PROJECT TO IMPLEMENT VESALIUS IN TONGA
Mar 2020 –The Ministry of Health, Kingdom of Tonga awarded VAMED, an international end-to-end provider of solutions to healthcare facilities – the project for management, implementation and support of the nationwide Health Information System (HIS) and Electronic Medical Record (EMR). Tonga has a population of about 107,000 people living on 170 islands spread across 750,000 square kilometers in the southern…
SELENA+ OBTAINS APPROVAL FOR MARKET ACCESS IN EU
9 Mar 2020 – EyRIS is pleased to announce that SELENA+, a deep learning AI system designed to detect diabetic retinopathy, glaucoma-suspect and age-related macular degeneration, jointly invented by clinicians and scientists from Singapore Eye Research Institute (SERI) and NUS School of Computing has received CE Marking certification. EyRIS is a start-up company established to commercialise SELENA+, which was trained…